Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors: A Chinese population-based study/Experiment 1/Signature 1

From BugSigDB
Reviewed Marked as Reviewed by Fatima on 2022/08/17

Curated date: 2022/07/15

Curator: Sharmilac

Revision editor(s): Sharmilac, Fatima

Source: Figure 1b

Description: Compositional differences in the gut microbiome are associated with responses to anti-PD-1 immunotherapy.

Abundance in Group 1: increased abundance in Responders

NCBI Quality ControlLinks
Clostridia
Faecalibacterium
Faecalibacterium prausnitzii
Bacillota
Micrococcaceae
Mollicutes
Oscillospiraceae
Peptoniphilus
Phascolarctobacterium
Phascolarctobacterium faecium
Porphyromonas pasteri
Rothia
Ruminiclostridium hungatei
Ruminococcus
Ruminococcus bromii
Veillonellaceae
Eubacteriales

Revision editor(s): Sharmilac, Fatima